製品の概要
CL-218,872 is a novel sedative and hypnotic compound. Unlike traditional benzodiazepines, it belongs to a unique class of nonbenzodiazepine hypnotics. The compound is particularly noted for its selective action on the GABA A receptor, specifically targeting the α1 subtype.
Chemical and Pharmacological Properties:
The molecular structure of CL-218,872 differentiates it from benzodiazepines, contributing to its unique pharmacological profile. Its action as a partial agonist at the GABA A receptor sites leads to sedative, anxiolytic, anticonvulsant, and amnestic effects, with a reduced risk of dependency compared to traditional benzodiazepines.
用法・用量
The optimal dosage of CL-218,872 varies depending on the intended use and the subject’s physiology. In research settings, dosages are carefully controlled and monitored.
Therapeutic Effects:
CL-218,872 is primarily used in research for its sedative and hypnotic effects. It has shown potential in studies for inducing sleep and reducing anxiety, with a faster onset and shorter duration of action, making it advantageous for specific therapeutic applications.
Side Effects and Harm Reduction:
Like all sedative-hypnotics, CL-218,872 can cause side effects such as dizziness, confusion, and motor impairment. Long-term use or misuse can lead to tolerance and dependence. Its safety profile, however, indicates a lower risk of these adverse effects compared to traditional benzodiazepines. Harm reduction strategies involve controlled administration, monitoring for adverse reactions, and avoiding use with other central nervous system depressants.
Comparative Analysis:
In comparison to other hypnotics like triazolam or zolpidem, CL-218,872 offers a unique balance of efficacy and safety, making it a subject of interest in both pharmacological research and potential clinical use.
なぜ買うのか CL-218,872 EU from RECHEMCO?
私たちは市場で長い取引の歴史を持っているので、あなたは私たちの経験から利益を得ることができます。
★ CL-218,872 がテストされ、検証された。
★ We accept various payment methods such as Bitcoin, Monero, many other cryptocurrencies and bank wire.
ご購入時にお渡しするもの CL-218,872 EU from RECHEMCO?
- 最高級のアルミ箔入り密封袋1袋 CL-218,872 EU
• Graysh powder
• 98-99% Purity
Lygelll (承認) -
There’s lots of hate about this chemical. I tried it yesterday, vaped in a small amount. I definitly appreciated it ! It has little to no anxiolisis (on me, who not actually under benzo tolerance), a nice clear headed sedation combined with a pleasing, all emcompassing, hypnosis. Some amnesic effects (significant). I may add that the flavor is okay and it is not harsh… Slept fantastically deeply. I’m determined to put this alternative benzo to the test soon again ! Thanks to Rechemco
レケムコ -
Thank you for sharing your detailed experience—it’s always valuable to hear firsthand accounts, as they contribute to a deeper understanding of this compound’s effects. Your observations on its sedation, hypnosis, and amnesic properties are especially interesting.
That said, we must emphasize that this is a research chemical, intended strictly for laboratory use and not for human consumption. These substances carry significant risks, including unpredictable effects, potential dependence, and lack of safety data. Always prioritize harm reduction and consult medical professionals regarding any substance use.
Stay safe, and thanks again for the review!”